BALYASNY ASSET MANAGEMENT L.P.

Q1 2025 13F-HR Detailed Holdings

Location
Chicago, IL
Holdings as of
3/31/2025
Date filed
5/15/2025
Form type
13F-HR
Num holdings
2,727
Total value ($000)
$60,484,647
Net value change ($000)
-6,654,297 (-9.9%)
New positions
594
Sold out positions
511
Turnover %
30.1%
Sector allocation + QoQ delta (equities-only)

Holdings broken out by other managers reported in the original SEC filing. View aggregated holdings

You are on the SEC detailed breakdown page. Rows are shown as reported in the filing (including other manager, discretion, and voting authority fields), and are not merged like the standard holdings view. Switch to aggregated holdings.

Snapshot: Change Analysis

Compared to Q4 2024
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
IVV 482,628 1575.9%
MA 407,265 6312.2%
SCHW 400,366 2816.5%
Intra-Cellular Therapies, Inc. 286,200 2453.7%
INTU 281,163 403.2%
SPY 270,230 73.4%
AZO 255,205 NEW
MNST 235,245 1506.2%
DHR 232,180 3693.6%
META 230,729 188.9%
Top Reduces (Value $000, Stocks/ETFs)
CRM -384,670 -93.0%
AJG -373,901 -99.8%
KO -366,625 -98.6%
SBUX -330,271 -100.0%
PNC -273,860 -100.0%
ANET -258,202 -100.0%
CSCO -234,492 -97.2%
ASML -234,307 -88.5%
TSM -229,679 -52.8%
WMT -228,297 -99.5%
Instrument mix + QoQ Δ (ex-options)
Derivatives reported exposure ($000): 20,581,503 (34.0% of total reported value)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type Discretion Other Manager Sole Shared None